Senescence and immortalization of human cells

Biogerontology

Volumn 1, Issue 2, 2000, Pages 103-121

  Duncan, Emma L ^a   Wadhwa, Renu ^b   Kaul, Sunil C ^a  

^a NATIONAL INSTITUTE OF ADVANCED INDUSTRIAL SCIENCE AND TECHNOLOGY AIST   (Japan)

^b CHUGAI PHARMACEUTICAL CO LTD   (Japan)

Author keywords

Human; Immortalization; Senescence

Indexed keywords

PROTEIN P16INK4A; PROTEIN P53; RETINOBLASTOMA PROTEIN;

ANIMAL; CELL AGING; GENETICS; HUMAN; METABOLISM; PHYSIOLOGY; REVIEW; TELOMERE;

ANIMALS; CELL AGING; CYCLIN-DEPENDENT KINASE INHIBITOR P16; HUMANS; RETINOBLASTOMA PROTEIN; TELOMERE; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0034575087     PISSN: 13895729     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1010000132671     Document Type: Review

References (273)

1. Afshari CA, Vojta PJ, Annab LA, Futreal PA, Willard TB and Barrett JC (1993) Investigation of the role of G1/S cell cycle mediators in cellular senescence. Exp Cell Res 209: 231-237
2. Alani RM, Hasskarl J, Grace M, Hernandez MC, Israel MA and Münger K (1999) Immortalization of primary human keratinocytes by the helix-loop-helix protein, Id-1. Proc Natl Acad Sci USA 96: 9637-9641
3. Alcorta DA, Xiong Y, Phelps D, Hannon G, Beach D and Barrett JC (1996) Involvement of the cyclin-dependent kinase inhibitor p16 (INK4a) in replicative senescence of normal human fibroblasts. Proc Natl Acad Sci USA 93: 13742-13747
4. Allshire RC, Gosden JR, Cross SH, Cranston G, Rout D, Sugawara N, Szostak JW, Fantes PA and Hastie ND (1988) Telomeric repeat from T. thermophila cross hybridizes with human telomeres. Nature 332: 656-659
5. Allsopp RC (1996) Models of initiation of replicative senescence by loss of telomeric DNA. Exp Gerontol 31: 235-243
6. Allsopp RC and Harley CB (1995) Evidence for a critical telomere length in senescent human fibroblasts. Exp Cell Res 219: 130-136
7. Allsopp RC, Vaziri H, Patterson C, Goldstein S, Younglai EV, Futcher AB, Greider CW and Harley CB (1992) Telomere length predicts replicative capacity of human fibroblasts. Proc Natl Acad Sci USA 89: 10114-10118
8. Andrews GK (1990) Regulation of metallothionein gene expression. Prog Food Nutr Sci 14: 193-258
9. Antequera F, Boyes J and Bird A (1990) High levels of de novo methylation and altered chromatin structure at CpG islands in cell lines. Cell 62: 503-514
10. Atadja P, Wong H, Garkavtsev I, Veillette C and Riabowol K (1995) Increased activity of p53 in senescing fibroblasts. Proc Natl Acad Sci USA 92: 8348-8352
11. Avilion AA, Piatyszek MA, Gupta J, Shay JW, Bacchetti S and Greider CW (1996) Human telomerase RNA and telomerase activity in immortal cell lines and tumor tissues. Cancer Res 56: 645-650
12. Bender CM, Pao MM and Jones PA (1998) Inhibition of DNA methylation by 5-aza-2′-deoxycytidine suppresses the growth of human tumor cell lines. Cancer Res 58: 95-101
13. Bertram MJ, Bérubé NG, Hang-Swanson X, Ran Q, Leung JK, Bryce S, Spurgers K, Bick RJ, Baldini A, Ning Y, Clark LJ, Parkinson EK, Barrett JC, Smith JR and Pereira-Smith OM (1999) Identification of a gene that reverses the immortal phenotype of a subset of cells and is a member of a novel family of transcription factor-like genes. Mol Cell Biol 19: 1479-1485
14. Bischoff FZ, Yim SO, Pathak S, Grant G, Siciliano MJ, Giovanella BC, Strong LC and Tainsky MA (1990) Spontaneous abnormalities in normal fibroblasts from patients with Li-Fraumeni cancer syndrome: aneuploidy and immortalization. Cancer Res 50: 7979-7984
15. Blackburn EH (1991) Structure and function of telomeres. Nature 350: 569-573
16. Blasco MA, Funk W, Villeponteau B and Greider CW (1995) Functional characterization and developmental regulation of mouse telomerase RNA. Science 269: 1267-1270
17. Blasco MA, Lee HW, Hande MP, Samper E, Lansdorp PM, DePinho RA and Greider CW (1997) Telomere shortening and tumor formation by mouse cells lacking telomerase RNA. Cell 91: 25-34
18. Bodnar AG, Ouellette M, Frolkis M, Holt SE, Chiu CP, Monn GB, Harley, C B, Shay JW, Lichtsteiner, S and Wright WE (1998) Extension of life-span by introduction of telomerase into normal human cells. Science 279: 349-352
19. Bond J, Haughton M, Blaydes J, Gire V, Wynford-Thomas D and Wyllie F (1996) Evidence that transcriptional activation by p53 plays a direct role in the induction of cellular senescence. Oncogene 13: 2097-2104
20. Bond JA, Blaydes JP, Rowson J, Haughton MF, Smith JR, Wynford-Thomas D and Wyllie FS (1995) Mutant p53 rescues human diploid cells from senescence without inhibiting the induction of SDI1/WAF1. Cancer Res 55: 2404-2409
21. Bond JA, Haughton MF, Rowson JM, Smith PJ, Gire V, Wynford-Thomas D and Wyllie FS (1999) Control of replicative life span in human cells: barriers to clonal expansion intermediate between M1 senescence and M2 crisis. Mol Cell Biol 19: 3103-3114
22. Bond JA, Wyllie FS and Wynford-Thomas D (1994) Escape from senescence in human diploid fibroblasts induced directly by mutant p53. Oncogene 9: 1885-1889
23. Brenner AJ, Stampfer MR and Aldaz CM (1998) Increased p16 expression with first senescence arrest in human mammary epithelial cells and extended growth capacity with p16 inactivation. Oncogene 17: 199-205
24. Broccoli D, Young JW and de Lange T (1995) Telomerase activity in normal and malignant hematopoietic cells. Proc Natl Acad Sci USA 92: 9082-9086
25. Brooks-Frederich KM, Cianciarulo FL, Rittling SR and Cristofalo VJ (1993) Cell cycle-dependent regulation of Ca2+ in young and senescent WI-38 cells. Exp Cell Res 205: 412-415
26. Brown JP, Wei W and Sedivy JM (1997) Bypass of senescence after disruption of p21CIP1/WAF1 gene in normal diploid human fibroblasts. Science 277: 831-834
27. Bryan TM and Cech TR (1999) Telomerase and the maintenance of chromosome ends. Curr Opin Cell Biol 11: 318-324
28. Bryan TM and Reddel RR (1994) SV40-induced immortalization of human cells. Crit Rev Oncog 5: 331-357
29. Bryan TM and Reddel RR (1997) Telomere dynamics and telomerase activity in in vitro immortalised human cells. Eur J Cancer 33: 767-773
30. Bryan TM, Englezou A, Dalla-Pozza L, Dunham MA and Reddel RR (1997) Evidence for an alternative mechanism for maintaining telomere length in human tumors and tumor-derived cell lines. Nat Med 3: 1271-1274
31. Bryan TM, Englezou A, Gupta J, Bacchetti S and Reddel RR (1995) Telomere elongation in immortal human cells without detectable telomerase activity. EMBO J 14: 4240-4248
32. Bunn CL and Tarrant GM (1980) Limited lifespan in somatic cell hybrids and cybrids. Exp Cell Res 127: 385-396
33. Campisi J (1992) Oncogenes, protooncogenes, and tumor suppressor genes: a hitchhiker's guide to senescence? Exp Gerontol 27: 397-401
34. Campisi J (1997) The biology of replicative senescence. Eur J Cancer 33: 703-709
35. Campisi J, Dimri GP, Nehlin JO, Testori A and Yoshimoto K (1996) Coming of age in culture. Exp Gerontol 31: 7-12
36. Chang T, Khalsa O, Wang H, Lee ME and Schlegel R (1996) Staurosporine resistance accompanies DNA tumor virus-induced immortalization and is independent of the expression and activities of ERK1, ERK2, cyclin A, cyclin-dependent kinase (cdk) 2, and cdk4. Cell Growth Differ 7: 361-372
37. Chen Q and Ames BN (1994) Senescence-like growth arrest induced by hydrogen peroxide in human diploid fibroblast F65 cells. Proc Natl Acad Sci USA 91: 4130-4134
38. Chen Q, Fischer A, Reagan JD, Yan LJ and Ames BN (1995) Oxidative DNA damage and senescence of human diploid fibroblast cells. Proc Natl Acad Sci USA 92: 4337-4341
39. Chen QM, Bartholomew JC, Campisi J, Acosta M, Reagan JD and Ames BN (1998) Molecular analysis of H2O2-induced senescent-like growth arrest in normal human fibroblasts: p53 and Rb control G1 arrest but not cell replication. Biochem J 332 (Pt 1): 43-50
40. Coates PJ, Jamieson DJ, Smart K, Prescott AR and Hall PA (1997) The prohibitin family of mitochondrial proteins regulate replicative lifespan. Curr Biol 7: 607-610
41. Cohen DR and Curran T (1989) The structure and function of the fos proto-oncogene. Crit Rev Oncog 1: 65-88
42. Colgin LM and Reddel RR (1999) Telomere maintenance mechanisms and cellular immortalization. Curr Opin Genet Dev 9: 97-103
43. Cooke HJ and Smith BA (1986) Variability at the telomeres of the human X/Y pseudoautosomal region. Cold Spring Harb Symp Quant Biol 51 (Pt 1): 213-219
44. Counter CM, Avilion AA, LeFeuvre CE, Stewart NG, Greider CW, Harley CB and Bacchetti S (1992) Telomere shortening associated with chromosome instability is arrested in immortal cells which express telomerase activity. EMBO J 11: 1921-1929
45. Counter CM, Botelho FM, Wang P, Harley CB and Bacchetti S (1994a) Stabilization of short telomeres and telomerase activity accompany immortalization of Epstein-Barr virus-transformed human B lymphocytes. J Virol 68: 3410-3414
46. Counter CM, Gupta J, Harley CB, Leber B and Bacchetti S (1995) Telomerase activity in normal leukocytes and in hematologic malignancies. Blood 85: 2315-2320
47. Counter CM, Hahn WC, Wei W, Caddle SD, Beijersbergen RL, Lansdorp PM, Sedivy JM and Weinberg RA (1998a) Dissociation among in vitro telomerase activity, telomere maintenance, and cellular immortalization. Proc Natl Acad Sci USA 95: 14723-14728
48. Counter CM, Hirte HW, Bacchetti S and Harley CB (1994b) Telomerase activity in human ovarian carcinoma [see comments]. Proc Natl Acad Sci USA 91: 2900-2904
49. Counter CM, Meyerson M, Eaton EN, Ellisen LW, Caddle SD, Haber DA and Weinberg RA (1998b) Telomerase activity is restored in human cells by ectopic expression of hTERT (hEST2), the catalytic subunit of telomerase. Oncogene 16: 1217-1222
50. Cristofalo VJ and Pignolo RJ (1993) Replicative senescence of human fibroblast-like cells in culture. Physiol Rev 73: 617-638
51. Cristofalo VJ, Phillips PD, Sorger T and Gerhard G (1989) Alterations in the responsiveness of senescent cells to growth factors. J Gerontol 44: 55-62
52. Cristofalo VJ, Allen RG, Pignolo RJ, Martin BG and Beck JC (1998a) Relationship between donor age and the replicative lifespan of human cells in culture: a reevaluation. Proc Natl Acad Sci USA 95: 10614-10619
53. Cristofalo VJ, Volker C, Francis MK and Tresini M (1998b) Age-dependent modifications of gene expression in human fibroblasts. Crit Rev Eukaryot Gene Expr 8: 43-80
54. de Lange T (1994) Activation of telomerase in a human tumor [comment]. Proc Natl Acad Sci USA 91: 2882-2885
55. de Lange T, Shiue L, Myers RM, Cox DR, Naylor SL, Killery AM and Varmus HE (1990) Structure and variability of human chromosome ends. Mol Cell Biol 10: 518-527
56. De Tata V, Ptasznik A and Cristofalo VJ (1993) Effect of the tumor promoter phorbol 12-myristate 13-acetate (PMA) on proliferation of young and senescent WI-38 human diploid fibroblasts. Exp Cell Res 205: 261-269
57. Della Ragione FD, Russo GL, Oliva A, Mercurio C, Mastropietro S, Pietra VD and Zappia V (1996) Biochemical characterization of p16INK4- and p18-containing complexes in human cell lines. J Biol Chem 271: 15942-15949
58. Di Leonardo A, Linke SP, Clarkin K and Wahl GM (1994) DNA damage triggers a prolonged p53-dependent G1 arrest and long-term induction of Cip1 in normal human fibroblasts. Genes Dev 8: 2540-2551
59. Dimn GP, Lee X, Basile G, Acosta M, Scott G, Roskelley C, Medrano EE, Linskens M, Rubelj I, Pereira-Smith O, et al. (1995) A biomarker that identifies senescent human cells in culture and in aging skin in vivo. Proc Natl Acad Sci USA 92: 9363-9367
60. Ducray C, Pommier JP, Martins L, Boussin FD and Sabatier L (1999) Telomere dynamics, end-to-end fusions and telomerase activation during the human fibroblast immortalization process. Oncogene 18: 4211-4223
61. Dulic V, Kaufmann WK, Wilson SJ, Tlsty TD, Lees E, Harper JW, Elledge SJ and Reed SI (1994) p53-dependent inhibition of cyclin-dependent kinase activities in human fibroblasts during radiation-induced G1 arrest. Cell 76: 1013-1023
62. Duncan EL and Reddel RR (1997) Genetic changes associated with immortalization. A review. Biochemistry (Mosc) 62: 1263-1274
63. Duncan EL and Reddel RR (1999) Downregulation of metallothionein-IIA expression occurs at immortalization. Oncogene 18: 897-903
64. Dyson N (1994) pRB, p107 and the regulation of the E2F transcription factor. J Cell Sci Suppl 18: 81-87
65. el-Deiry WS, Nelkin BD, Celano P, Yen RW, Falco JP, Hamilton SR and Baylin SB (1991) High expression of the DNA methyltransferase gene characterizes human neoplastic cells and progression stages of colon cancer. Proc Natl Acad Sci USA 88: 3470-3474
66. Fang L, Igarashi M, Leung J, Sugrue MM, Lee SW and Aaronson SA (1999) p21Waf1/Cip1/Sdi1 induces permanent growth arrest with markers of replicative senescence in human tumor cells lacking functional p53. Oncogene 18: 2789-2797
67. Faragher RG and Kipling D (1998) How might replicative senescence contribute to human ageing? Bioessays 20: 985-991
68. Feng J, Funk WD, Wang SS, Weinrich SL, Avilion AA, Chiu CP, Adams RR, Chang E, Allsopp RC, Yu J, et al. (1995) The RNA component of human telomerase. Science 269: 1236-1241
69. Frenck RWJ, Blackburn EH and Shannon KM (1998) The rate of telomere sequence loss in human leukocytes varies with age. Proc Natl Acad Sci USA 95: 5607-5610
70. Fujii M, Ide T, Wadhwa R, Tahara H, Kaul SC, Mitsui Y, Ogata T, Oishi M and Ayusawa D (1995a) Inhibitors of cGMP-dependent protein kinase block senescence induced by inactivation of T antigen in SV40-transformed immortal human fibroblasts. Oncogene 11: 627-634
71. Fujii M, Ogata T, Takahashi E, Yamada K, Nakabayashi K, Oishi M and Ayusawa D (1995b) Expression of the human cgMP-dependent protein kinase II gene is lost upon introduction of SV40 T antigen or immortalization in human cells. FEBS Lett 375: 263-267
72. Furumoto K, Inoue E, Nagao N, Hiyama E and Miwa N (1998) Age-dependent telomere shortening is slowed down by enrichment of intracellular vitamin C via suppression of oxidative stress. Life Sci 63: 935-948
73. Fushimi K, Iijima M, Gao C, Kondo T, Tsuji T, Hashimoto T, Mihara K and Namba M (1997) Transformation of normal human fibroblasts into immortalized cells with the mutant p53 gene and X-rays. Int J Cancer 70: 135-140
74. Futreal PA and Barrett JC (1991) Failure of senescent cells to phosphorylate the RB protein. Oncogene 6: 1109-1113
75. Gadbois DM, Crissman HA, Tobey RA and Bradbury EM (1992) Multiple kinase arrest points in the G1 phase of nontransformed mammalian cells are absent in transformed cells. Proc Natl Acad Sci USA 89: 8626-8630
76. Gallimore PH, Lecane PS, Roberts S, Rookes SM, Grand RJ and Parkhill J (1997) Adenovirus type 12 early region 1B 54K protein significantly extends the life span of normal mammalian cells in culture. J Virol 71: 6629-6640
77. Garkavtsev I and Riabowol K (1997) Extension of the replicative life span of human diploid fibroblasts by inhibition of the p33ING1 candidate tumor suppressor. Mol Cell Biol 17: 2014-2019
78. Garkavtsev I, Grigorian IA, Ossovskaya VS, Chernov MV, Chumakov PM and Gudkov AV (1998) The candidate tumour suppressor p33ING1 cooperates with p53 in cell growth control. Nature 391: 295-298
79. Garkavtsev I, Kazarov A, Gudkov A and Riabowol K (1996) Suppression of the novel growth inhibitor p33ING1 promotes neoplastic transformation. Nat Genet 14: 415-420
80. Gire V and Wynford-Thomas D (1998) Reinitiation of DNA synthesis and cell division in senescent human fibroblasts by microinjection of anti-p53 antibodies. Mol Cell Biol 18: 1611-1621
81. Goldstein S (1969) Lifespan of cultured cells in progeria. Lancet 1: 424
82. Goldstein S (1990) Replicative senescence: the human fibroblast comes of age. Science 249: 1129-1133
83. Gollahon LS, Kraus E, Wu TA, Yim SO, Strong LC, Shay JW and Tainsky MA (1998) Telomerase activity during spontaneous immortalization of Li-Fraumeni syndrome skin fibroblasts. Oncogene 17: 709-717
84. Greenberg RA, O'Hagan RC, Deng H, Xiao Q, Hann SR, Adams RR, Lichtsteiner S, Chin L, Morin GB and DePinho RA (1999) Telomerase reverse transcriptase gene is a direct target of c-Myc but is not functionally equivalent in cellular transformation. Oncogene 18: 1219-1226
85. Greider CW and Blackburn EH (1985) Identification of a specific telomere terminal transferase activity in Tetrahymena extracts. Cell 43: 405-413
86. Hahn WC, Counter CM, Lundberg AS, Beijersbergen RL, Brooks MW and Weinberg RA (1999a) Creation of human tumour cells with defined genetic elements. Nature 400: 464-468
87. Hahn WC, Stewart SA, Brooks MW, York SG, Eaton E, Kurachi A, Beijersbergen RL, Knoll JHM, Meyerson M and Weinberg RA (1999b) Inhibition of telomerase limits the growth of human cancer cells. Nat Med 5: 1164-1170
88. Halevy O, Novitch BG, Spicer DB, Skapek SX, Rhee J, Hannon GJ, Beach D and Lassar AB (1995) Correlation of terminal cell cycle arrest of skeletal muscle with induction of p21 by MyoD. Science 267: 1018-1021
89. Halvorsen TL, Leibowitz G and Levine F (1999) Telomerase activity is sufficient to allow transformed cells to escape from crisis. Mol Cell Biol 19: 1864-1870
90. Hara E, Tsurui H, Shinozaki A, Nakada S and Oda K (1991) Cooperative effect of antisense-Rb and antisense-p53 oligomers on the extension of life span in human diploid fibroblasts, TIG-1. Biochem Biophys Res Commun 179: 528-534
91. Hara E, Yamaguchi T, Nojima H, Ide T, Campisi J, Okayama H and Oda K (1994) Id-related genes encoding helix-loop-helix proteins are required for G1 progression and are repressed in senescent human fibroblasts. J Biol Chem 269: 2139-2145
92. Hara E, Smith R, Parry D, Tahara H, Stone S and Peters G (1996a) Regulation of p16CDKN2 expression and its implications for cell immortalization and senescence. Mol Cell Biol 16: 859-867
93. Hara E, Uzman JA, Dimri GP, Nehlin JO, Testori A and Campisi J (1996b) The helix-loop-helix protein Id-1 and a retinoblastoma protein binding mutant of SV40 T antigen synergize to reactivate DNA synthesis in senescent human fibroblasts. Dev Genet 18: 161-172
94. Härle-Bachor C and Boukamp P (1996) Telomerase activity in the regenerative basal layer of the epidermis inhuman skin and in immortal and carcinoma-derived skin keratinocytes. Proc Natl Acad Sci USA 93: 6476-6481
95. Harley CB (1991) Telomere loss: mitotic clock or genetic time bomb? Mutat Res 256: 271-282
96. Harley CB, Futcher AB and Greider CW (1990) Telomeres shorten during ageing of human fibroblasts. Nature 345: 458-460
97. Harley CB, Vaziri H, Counter CM and Allsopp RC (1992) The telomere hypothesis of cellular aging. Exp Gerontol 27: 375-382
98. Harper JW, Adami GR, Wei N, Keyomarsi K and Elledge SJ (1993) The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases. Cell 75: 805-816
99. Harrington L, McPhail T, Mar V, Zhou W, Oulton R, Bass MB, Arruda I and Robinson MO (1997a) A mammalian telomerase-associated protein. Science 275: 973-977
100. Harrington L, Zhou W, McPhail T, Oulton R, Yeung DS, Mar V, Bass MB and Robinson MO (1997b) Human telomerase contains evolutionarily conserved catalytic and structural subunits. Genes Dev 11: 3109-3115
101. Harris LC, von Wronski MA, Venable CC, Remack JS, Howell SR and Brent TP (1996) Changes in O6-methylguanine-DNA methyltransferase expression during immortalization of cloned human fibroblasts. Carcinogenesis 17: 219-224
102. Hastie ND, Dempster M, Dunlop MG, Thompson AM, Green DK and Allshire RC (1990) Telomere reduction in human colorectal carcinoma and with ageing. Nature 346: 866-868
103. Hayflick L (1965) The limited in vitro lifetime of human diploid cell strains. Exp Cell Res 37: 614-636
104. Hayflick L and Moorhead PS (1961) The serial cultivation of human diploid cell strains. Exp Cell Res 25: 585-621
105. Helbing CC, Veillette C, Riabowol K, Johnston RN and Garkavtsev I (1997) A novel candidate tumor suppressor, ING1, is involved in the regulation of apoptosis. Cancer Res 57: 1255-1258
106. Hensler PJ, Annab LA, Barrett JC and Pereira-Smith OM (1994) A gene involved in control of human cellular senescence on human chromosome 1q. Mol Cell Biol 14: 2291-2297
107. Hiyama K, Hirai Y, Kyoizumi S, Akiyama M, Hiyama E, Piatyszek MA, Shay JW, Ishioka S and Yamakido M (1995) Activation of telomerase in human lymphocytes and hematopoietic progenitor cells. J Immunol 155: 3711-3715
108. Holliday R (1990) The limited proliferation of cultured human diploid cells: regulation or senescence? J Gerontol 45: B36-B41
109. Holliday R and Pugh JE (1975) DNA modification mechanisms and gene activity during development. Science 187: 226-232
110. Holt SE, Aisner DL, Baur J, Tesmer VM, Dy M, Ouellette M, Trager JB, Monn GB, Toft DO, Shay JW, Wright WE and White MA (1999) Functional requirement of p23 and Hsp90 in telomerase complexes. Genes Dev 13: 817-826
111. Holt SE and Shay JW (1999) Role of telomerase in cellular prolif-eration and cancer. J Cell Physiol 180: 10-18
112. Honda S and Matsuo M (1987) 5-Azacytidine shortens the in vitro lifespan of human diploid cells. Cell Biol Int Rep 11: 141
113. Horikawa I, Cable PL, Afshari C and Barrett JC (1999) Cloning and characterization of the promoter region of human telomerase reverse transcriptase gene. Cancer Res 59: 826-830
114. Horikawa I, Oshimura M and Barrett JC (1998) Repression of the telomerase catalytic subunit by a gene on human chromosome 3 that induces cellular senescence. Mol Carcinog 22: 65-72
115. Howard BH (1996) Replicative senescence: considerations relating to the stability of heterochromatin domains. Exp Gerontol 31: 281-293
116. Hsiao R, Sharma HW, Ramakrishnan S, Keith E and Narayanan R (1997) Telomerase activity in normal human endothelial cells. Anticancer Res 17: 827-832
117. Hubbard-Smith K, Patsalis P, Pardinas JR, Jha KK, Henderson AS and Ozer HL (1992) Altered chromosome 6 in immortal human fibroblasts. Mol Cell Biol 12: 2273-2281
118. Hukku B and Rhim JS (1993) Role of chromosome 5 in immortalization and tumorigenesis of human keratinocytes. Cancer Genet Cytogenet 68: 22-31
119. Huschtscha LI, Noble JR, Neumann AA, Moy EL, Barry P, Melki JR, Clark SJ and Reddel RR (1998) Loss of p16INK4 expression by methylation is associated with lifespan extension of human mammary epithelial cells. Cancer Res 58: 3508-3512
120. Issa JP, Vertino PM, Wu J, Sazawal S, Celano P, Nelkin BD, Hamilton SR and Baylin SB (1993) Increased cytosine DNA-methyltransferase activity during colon cancer progression. J Natl Cancer Inst 85: 1235-1240
121. Jarrard DF, Sarkar S, Shi Y, Yeager TR, Magrane G, Kinoshita H, Nassif N, Meisner L, Newton MA, Waldman FM and Reznikoff, CA (1999) p16/pRb pathway alterations are required for bypassing senescence in human prostate epithelial cells. Cancer Res 59: 2957-2964
122. Johnson M, Dimitrov D, Vojta PJ, Barrett JC, Noda A, Pereira-Smith OM and Smith JR (1994) Evidence for a p53-independent pathway for upregulation of SDI1/CIP1/WAF1/p21 RNA in human cells. Mol Carcinog 11: 59-64
123. Jupe ER, Liu XT, Kiehlbauch JL, McClung JK and Dell'Orco RT (1995) Prohibitin antiproliferative activity and lack of heterozygosity in immortalized cell lines. Exp Cell Res 218: 577-580
124. Jupe ER, Liu XT, Kiehlbauch JL, McClung JK and Dell'Orco RT (1996) Prohibitin in breast cancer cell lines: loss of antiproliferative activity is linked to 3′ untranslated region mutations. Cell Growth Differ 7: 871-878
125. Kallassy M, Martel N, Damour O, Yamasaki H and Nakazawa H (1998) Growth arrest of immortalized human keratinocytes and suppression of telomerase activity by p21WAF1 gene expression. Mol Carcinog 21: 26-36
126. Kaltoft K, Pedersen CB, Hansen BH and Thestrup-Pedersen K (1995) Appearance of isochromosome 18q can be associated with in vitro immortalization of human T lymphocytes. Cancer Genet Cytogenet 81: 13-16
127. Kaneko S, Satoh Y, Ikemura K, Konishi T, Ohji T, Karasaki Y, Higashi K and Gotoh S (1995) Alterations of expression of the cytoskeleton after immortalization of human fibroblasts. Cell Struct Funct 20: 107-115
128. Kang MK, Guo W and Park NH (1998) Replicative senescence of normal human oral keratinocytes is associated with the loss of telomerase activity without shortening of telomeres. Cell Growth Differ 9: 85-95
129. Kastan MB, Onyekwere O, Sidransky D, Vogelstein B and Craig RW (1991) Participation of p53 protein in the cellular response to DNA damage. Cancer Res 51: 6304-6311
130. Kato D, Miyazawa K, Ruas M, Starborg M, Wada I, Oka T, Sakai T, Peters G and Hara E (1998) Features of replicative senescence induced by direct addition of antennapedia-p16INK4A fusion protein to human diploid fibroblasts. FEBS Lett 427: 203-208
131. Kaul SC, Duncan EL, Englezou A, Takano S, Reddel RR, Mitsui Y and Wadhwa R (1998) Malignant transformation of NIH3T3 cells by overexpression of mot-2 protein. Oncogene 17: 907-911
132. Khleif SN, DeGregori J, Yee CL, Otterson GA, Kaye FJ, Nevins JR and Howley PM (1996) Inhibition of cyclin D-CDK4/CDK6 activity is associated with an E2F-mediated induction of cyclin kinase inhibitor activity. Proc Natl Acad Sci USA 93: 4350-4354
133. Kilian A, Bowtell DD, Abud HE, Hime GR, Venter DJ, Keese PK, Duncan EL, Reddel RR and Jefferson RA (1997) Isolation of a candidate human telomerase catalytic subunit gene, which reveals complex splicing patterns in different cell types. Hum Mol Genet 6: 2011-2019
134. Kim NW, Piatyszek MA, Prowse KR, Harley CB, West MD, Ho PL, Coviello GM, Wright WE, Weinrich SL and Shay JW (1994) Specific association of human telomerase activity with immortal cells and cancer. Science 266: 2011-2015
135. Kipling D and Cooke HJ (1990) Hypervariable ultra-long telomeres in mice. Nature 347: 400-402
136. Kirkland JL (1992) The biochemistry of mammalian senescence. Clin Biochem 25: 61-75
137. Kiyono T, Foster SA, Koop JI, McDougall JK, Galloway DA and Klingelhutz AJ (1998) Both Rb/p16INK4a inactivation and telomerase activity are required to immortalize human epithelial cells. Nature 396: 84-88
138. Klingelhutz AJ, Barber SA, Smith PP, Dyer K and McDougall JK (1994) Restoration of telomeres in human papillomavirus-immortalized human anogenital epithelial cells. Mol Cell Biol 14: 961-969
139. Kulju KS and Lehman JM (1995) Increased p53 protein associated with aging in human diploid fibroblasts. Exp Cell Res 217: 336-345
140. Lane DP (1992) Cancer. p53, guardian of the genome. Nature 1992; 358: 15-16
141. Lee AC, Fenster BE, Ito H, Takeda K, Bae NS, Hirai T, Yu ZX, Ferrans VJ, Howard BH and Finkel T (1999) Ras proteins induce senescence by altering the intracellular levels of reactive oxygen species. J Biol Chem 274: 7936-7940
142. Levy MZ, Allsopp RC, Futcher AB, Greider CW and Harley CB (1992) Telomere end-replication problem and cell aging. J Mol Biol 225: 951-960
143. Li H, Zhao L, Yang Z, Funder JW and Liu JP (1998) Telomerase is controlled by protein kinase Calpha in human breast cancer cells. J Biol Chem 273: 33436-33442
144. Li H, Zhao LL, Funder JW and Liu JP (1997) Protein phosphatase 2A inhibits nuclear telomerase activity in human breast cancer cells. J Biol Chem 272: 16729-16732
145. Li Y, Nichols MA, Shay JW and Xiong Y (1994) Transcnptional repression of the D-type cyclin-dependent kinase inhibitor p16 by the retinoblastoma susceptibility gene product pRb. Cancer Res 54: 6078-6082
146. Lin AW, Barradas M, Stone JC, van Aelst L, Serrano M and Lowe SW (1998) Premature senescence involving p53 and p16 is activated in response to constitutive MEK/MAPK mitogenic signaling. Genes Dev 12: 3008-3019
147. Lin JY and Simmons DT (1991) The ability of large T antigen to complex with p53 is necessary for the increased life span and partial transformation of human cells by simian virus 40. J Virol 65: 6447-6453
148. Linder S and Marshall H (1990) Immortalization of primary cells by DNA tumor viruses. Exp Cell Res 191: 1-7
149. Lindsey J, McGill NI, Lindsey LA, Green DK and Cooke HJ (1991) In vivo loss of telomeric repeats with age in humans. Mutat Res 256: 45-48
150. Liu XT, Stewart CA, King RL, Danner DA, Dell'Orco RT and McClung JK (1994) Prohibitin expression during cellular senescence of human diploid fibroblasts. Biochem Biophys Res Commun 201: 409-414
151. Luce MC, Schyberg JP and Bunn CL (1993) Metallothionem expression and stress responses in aging human diploid fibroblasts. Exp Gerontol 28: 17-38
152. Ludlow JW, DeCapno JA, Huang CM, Lee WH, Paucha E and Livingston DM (1989) SV40 large T antigen binds preferentially to an underphosphorylated member of the retinoblastoma susceptibility gene product family. Cell 56: 57-65
153. Maclean K, Rogan EM, Whitaker NJ, Chang AC, Rowe PB, Dalla-Pozza L, Symonds G and Reddel RR (1994) In vitro transformation of Li-Fraumeni syndrome fibroblasts by SV40 large T antigen mutants. Oncogene 9: 719-725
154. Makarov VL, Hirose Y and Langmore JP (1997) Long G tails at both ends of human chromosomes suggest a C strand degradation mechanism fortelomere shortening. Cell 88: 657-666
155. Matsumura T, Malik F and Holliday R (1989) Levels of DNA methylation in diploid and SV40 transformed human fibroblasts. Exp Gerontol 24: 477-481
156. McClung JK, Danner DB, Stewart DA, Smith JR, Schneider EL, Lumpkin CK, Dell'Orco RT and Nuell MJ (1989) Isolation of a cDNA that hybrid selects antiproliferative mRNA from rat liver. Biochem Biophys Res Commun 164: 1316-1322
157. McClung JK, King RL, Walker LS, Danner DB, Nuell MJ, Stewart CA and Dell'Orco RT (1992) Expression of prohibitin, an antiproliferative protein. Exp Gerontol 27: 413-417
158. McClung JK, Jupe ER, Liu XT and Dell'Orco RT (1995) Prohibitin: potential role in senescence, development, and tumor suppression. Exp Gerontol 30: 99-124
159. McConnell BB, Starborg M, Brookes S and Peters G (1998) Inhibitors of cyclin-dependent kinases induce features of replicative senescence in early passage human diploid fibroblasts. Curr Biol 8: 351-354
160. McEachern MJ and Blackburn EH (1995) Runaway telomere elongation caused by telomerase RNA gene mutations. Nature 1995; 376: 403-409
161. McElligott R and Wellinger RJ (1997) The terminal DNA structure of mammalian chromosomes. EMBO J 16: 3705-3714
162. Medcalf AS, Klein-Szanto AJ and Cnstofalo VJ (1996) Expression of p21 is not required for senescence of human fibroblasts. Cancer Res 56: 4582-4585
163. Meyerson M, Counter CM, Eaton EN, Ellisen LW, Steiner P, Caddle SD, Ziaugra L, Beijersbergen RL, Davidoff MJ, Liu Q, Bacchetti S, Haber DA and Weinberg RA (1997) hEST2, the putative human telomerase catalytic subunit gene, is up-regulated in tumor cells and during immortalization. Cell 90: 785-795
164. Meyyappan M, Wong H, Hull C and Riabowol KT (1998) Increased expression of cyclin D2 during multiple states of growth arrest in primary and established cells. Mol Cell Biol 18: 3163-3172
165. Michishita E, Nakabayashi K, Ogino H, Suzuki T, Fujii M and Ayusawa D (1998) DNA topoisomerase inhibitors induce reversible senescence in normal human fibroblasts. Biochem Biophys Res Commun 253: 667-671
166. Montalto MC, Phillips JS and Ray FA (1999) Telomerase activation in human fibroblasts during escape from crisis. J Cell Physiol 180: 46-52
167. Morales CP, Holt SE, Ouellette M, Kaur KJ, Yan Y, Wilson KS, White MA, Wright WE and Shay JW (1999) Absence of cancer-associated changes in human fibroblasts immortalized with telomerase. Nat Genet 21: 115-118
168. Morin GB (1989) The human telomere terminal transferase enzyme is a ribonucleoprotein that synthesizes TTAGGG repeats. Cell 59: 521-529
169. Moy EL, Duncan EL, Hukku B and Reddel RR (1997) Reassessment of immortalization complementation group D. Exp Gerontol 32: 663-670
170. Muggleton-Harris AL and DeSimone DW (1980) Replicative potentials of various fusion products between WI-38 and SV40 transformed WI-38 cells and their components. Somatic Cell Genet 6: 689-698
171. Munro J, Stott FJ, Vousden KH, Peters G and Parkinson EK (1999) Role of the alternative INK4A proteins in human keratinocyte senescence: evidence for the specific inactivation of p16INK4A upon immortalization. Cancer Res 59: 2516-2521
172. Murnane JP, Sabatier L, Marder BA and Morgan WF (1994) Telomere dynamics in an immortal human cell line. EMBO J 13: 4953-4962
173. Musgrove EA, Lilischkis R, Cornish AL, Lee CS, Setlur V, Seshadri R and Sutherland RL (1995) Expression of the cyclin-dependent kinase inhibitors p16INK4, p15INK4B and p21WAF1/CIP1 in human breast cancer. Int J Cancer 63: 584-591
174. Nakabayashi K, Ogata T, Fujii M, Tahara H, Ide T, Wadhwa R, Kaul SC, Mitsui Y and Ayusawa D (1997) Decrease in amplified telomeric sequences and induction of senescence markers by introduction of human chromosome 7 or its segments in SUSM-1. Exp Cell Res 235: 345-353
175. Nakamura TM, Morin GB, Chapman KB, Weinrich SL, Andrews WH, Lingner J, Harley CB and Cech TR (1997) Telomerase catalytic subunit homologs from fission yeast and human. Science 277: 955-959
176. Nakayama J, Saito M, Nakamura H, Matsuura A and Ishikawa F (1997) TLP1: a gene encoding a protein component of mammalian telomerase is a novel member of WD repeats family. Cell 88: 875-884
177. Nevins JR (1992) E2F: a link between the Rb tumor suppressor protein and viral oncoproteins. Science 258: 424-429
178. Niida H, Matsumoto T, Satoh H, Shiwa M, Tokutake Y, Furuichi Y and Shinkai Y (1998) Severe growth defect in mouse cells lacking the telomerase RNA component. Nat Genet 19: 203-206
179. Ning Y, Weber JL, Killary AM, Ledbetter DH, Smith JR and Pereira-Smith OM (1991) Genetic analysis of indefinite division in human cells: evidence for a
180. Noble JR, Rogan EM, Neumann AA, Maclean K, Bryan TM and Reddel RR (1996) Association of extended in vitro proliferative potential with loss of p16INK4 expression. Oncogene 13: 1259-1268
181. Noda A, Ning Y, Venable SF, Pereira-Smith OM and Smith JR (1994) Cloning of senescent cell-derived inhibitors of DNA synthesis using an expression screen. Exp Cell Res 211: 90-98
182. Nuell MJ, Stewart DA, Walker L, Friedman V, Wood CM, Owens GA, Smith JR, Schneider EL, Dell' Orco R, Lumpkin CK, et al. (1991) Prohibitin, an evolutionarily conserved intracellular protein that blocks DNA synthesis in normal fibroblasts and HeLa cells. Mol Cell Biol 11: 1372-1381
183. O'Brien W, Stenman G and Sager R (1986) Suppression of tumor growth by senescence in virally transformed human fibroblasts. Proc Natl Acad Sci USA 83: 8659-8663
184. Ogata T, Oshimura M, Namba M, Fujii M, Oishi M and Ayusawa D (1995) Genetic complementation of the immortal phenotype in group D cell lines by introduction of chromosome 7. Jpn J Cancer Res 86: 35-40
185. Ogryzko VV, Hirai TH, Russanova VR, Barbie DA and Howard BH (1996) Human fibroblast commitment to a senescence-like state in response to histone deacetylase inhibitors is cell cycle dependent. Mol Cell Biol 16: 5210-5218
186. Olovnikov AM (1971) Principle of marginotomy in template synthesis of polynucleotides. Doklady Akademii Nauk SSR 201: 1496-1499
187. Oshimura M and Barrett JC (1997) Multiple pathways to cellular senescence: role of telomerase repressors. Eur JCancer 33: 710-715
188. Ouellette MM, Aisner DL, Savre-Train I, Wright WE and Shay JW (1999) Telomerase activity does not always imply telomere maintenance. Biochem Biophys Res Commun 254: 795-803
189. Ozer HL, Banga SS, Dasgupta T, Houghton J, Hubbard K, Jha KK, Kim SH, Lenahan M, Pang Z, Pardinas JR and Patsalis PC (1996) SV40-mediated immortalization of human fibroblasts. Exp Gerontol 31: 303-310
190. Packer L and Fuehr K (1977) Low oxygen concentration extends the lifespan of cultured human diploid cells. Nature 267: 423-425
191. Pang JH and Chen KY (1994) Global change of gene expression at late G1/S boundary may occur in human IMR-90 diploid fibroblasts during senescence. J Cell Physiol 160: 531-538
192. Pereira-Smith OM and Smith JR (1981) Expression of SV40 T antigen in finite life-span hybrids of normal and SV40-transformed fibroblasts. Somatic Cell Genet 7: 411-421
193. Pereira-Smith OM and Smith JR (1983) Evidence for the recessive nature of cellular immortality. Science 221: 964-966
194. Pereira-Smith OM and Smith JR (1988) Genetic analysis of indefinite division in human cells: identification of four complementation groups. Proc Natl Acad Sci USA 85: 6042-6046
195. Perrem K, Bryan TM, Englezou A, Hackl T, Moy EL and Reddel RR (1999) Repression of an alternative mechanism for lengthening of telomeres in somatic cell hybrids. Oncogene 18: 3383-3390
196. Plummer SJ, Adams L, Simmons JA and Casey G (1997) Localization of a growth suppressor activity in MCF7 breast cancer cells to chromosome 17q24-q25. Oncogene 14: 2339-2345
197. Prives C and Hall PA (1999) The p53 pathway. J Pathol 187: 112-126
198. Radna RL, Caton Y, Jha KK, Kaplan P, Li G, Traganos F. and Ozer HL (1989) Growth of immortal simian virus 40 tsA-transformed human fibroblasts is temperature dependent. Mol Cell Biol 9: 3093-3096
199. Rattan SI (1996) Synthesis, modifications, and turnover of proteins during aging. Exp Gerontol 31: 33-47
200. Ray FA and Kraemer PM (1992) Frequent deletions in nine newly immortal human cell lines. Cancer Genet Cytogenet 59: 39-44
201. Reddel RR (1998) A reassessment of the telomere hypothesis of senescence. Bioessays 20: 977-984
202. Reznikoff CA, Yeager TR, Belair CD, Savelieva E, Puthenveettil JA and Stadler WM (1996) Elevated p16 at senescence and loss of p16 at immortalization in human papillomavirus 16 E6, but not E7, transformed human uroepithelial cells. Cancer Res 56: 2886-2890
203. Rhodes D and Giraldo R (1995) Telomere structure and function. Curr Opin Struct Biol 5: 311-322
204. Rice RH, Steinmann KE, deGraffenried LA, Qin Q, Taylor N and Schlegel R (1993) Elevation of cell cycle control proteins during spontaneous immortalization of human keratinocytes. Mol Biol Cell 4: 185-194
205. Robles SJ and Adami GR (1998) Agents that cause DNA double strand breaks lead to p16INK4a enrichment and the premature senescence of normal fibroblasts. Oncogene 16: 1113-1123
206. Rogan EM, Bryan TM, Hukku B, Maclean K, Chang AC, Moy EL, Englezou A, Warneford SG, Dalla-Pozza L and Reddel RR (1995) Alterations in p53 and p16INK4 expression and telomere length during spontaneous immortalization of Li-Fraumeni syndrome fibroblasts. Mol Cell Biol 15: 4745-4753
207. Röhme D (1981) Evidence for a relationship between longevity of mammlian species and life spans of normal fibroblasts in vitro and erythrocytes in vivo. Proc Natl Acad Sci USA 78: 5009-5013
208. Rosenberger RF (1991) Senescence and the accumulation of abnormal proteins. Mutat Res 256: 255-262
209. Sager R (1991) Senescence as a mode of tumor suppression. Environ Health Perspect 93: 59-62
210. Sandhu AK, Hubbard K, Kaur GP, Jha KK, Ozer HL and Athwal RS (1994) Senescence of immortal human fibroblasts by the introduction of normal human chromosome 6. Proc Natl Acad Sci USA 91: 5498-5502
211. Saretzki G, Feng J, von Zglinicki T and Villeponteau B (1998) Similar gene expression pattern in senescent and hyperoxic-treated fibroblasts. J Gerontol A Biol Sci Med Sci 53: B438-B442
212. Savelieva E, Belair CD, Newton MA, DeVries S, Gray JW, Waldman F and Reznikoff CA (1997) 20q gain associates with immortalization: 20q13.2 amplification correlates with genome instability in human papillomavirus 16 E7 transformed human uroepithelial cells. Oncogene 14: 551-560
213. Sawa H, Kamada H, Ohshima TA, Noguchi A, Itoh N, Saruta K, Hara M and Saito I (1999) Exogenous expression of p16INK4a is associated with decrease in telomerase activity. J Neurooncol 42: 45-57
214. Schulze A, Zerfass K, Spitkovsky D, Henglein B and Jansen-Durr P (1994) Activation of the E2F transcription factor by cyclin D1 is blocked by p16INK4, the product of the putative tumor suppressor gene MTS1. Oncogene 9: 3475-3482
215. Serrano M, Hannon GJ and Beach D (1993) A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4. Nature 366: 704-707
216. Serrano M, Gómez-Lahoz E, DePinho RA, Beach D and Bar-Sagi D (1995) Inhibition of ras-induced proliferation and cellular transformation by p16INK4. Science 267: 249-252
217. Serrano M, Lin AW, McCurrach ME, Beach D and Lowe SW (1997) Oncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16INK4a. Cell 88: 593-602
218. Shay JW and Wright WE (1989) Quantitation of the frequency of immortalization of normal human diploid fibroblasts by SV40 large T-antigen. Exp Cell Res 184: 109-118
219. Shay JW, West MD and Wright WE (1992) Re-expression of senescent markers in deinduced reversibly immortalized cells. Exp Gerontol 27: 477-492
220. Shay JW, Van Der Haegen BA, Ying Y and Wright WE (1993a) The frequency of immortalization of human fibroblasts and mammary epithelial cells transfected with SV40 large T-antigen. Exp Cell Res 209: 45-52
221. Shay JW, Wright WE, Brasiskyte D and Van der Haegen BA (1993b) E6 of human papillomavirus type 16 can overcome the M1 stage of immortalization in human mammary epithelial cells but not in human fibroblasts. Oncogene 8: 1407-1413
222. Shay JW, Tomlinson G, Piatyszek MA and Gollahon LS (1995) Spontaneous in vitro immortalization of breast epithelial cells from a patient with Li-Fraumeni syndrome. Mol Cell Biol 15: 425-432
223. Sherwood SW, Rush D, Ellsworth JL and Schimke RT (1988) Defining cellular senescence in IMR-90 cells: a flow cytometric analysis. Proc Natl Acad Sci USA 85: 9086-9090
224. Shibanuma M, Mashimo J, Kuroki T and Nose K (1994) Characterization of the TGF beta 1-inducible hic-5 gene that encodes a putative novel zinc finger protein and its possible involvement in cellular senescence. J Biol Chem 269: 26767-26674
225. Shibanuma M, Mochizuki E, Maniwa R, Mashimo J, Nishiya N, Imai S, Takano T, Oshimura M and Nose K (1997) Induction of senescence-like phenotypes by forced expression of hic-5, which encodes a novel LIM motif protein, in immortalized human fibroblasts. Mol Cell Biol 17: 1224-1235
226. Simons JW, Bols BL and Naaktgeboren JM (1990) Immortalization as an endpoint in studies on malignant transformation. Prog Clin Biol Res 340D: 207-217
227. Smith JR and Pereira-Smith OM (1990) Genetic and molecular studies of cellular immortalization. Adv Cancer Res 54: 63-77
228. Stein GH, Beeson M and Gordon L (1990) Failure to phosphorylate the retinoblastoma gene product in senescent human fibroblasts. Science 249: 666-669
229. Stein GH, Drullinger LF, Soulard A and Dulic V (1999) Differential roles for cyclin-dependent kinase inhibitors p21 and p16 in the mechanisms of senescence and differentiation in human fibroblasts. Mol Cell Biol 19: 2109-2117
230. Strauss M, Hering S, Lieber A, Herrmann G, Griffin BE and Arnold W (1992) Stimulation of cell division and fibroblast focus formation by antisense repression of retinoblastoma protein synthesis. Oncogene 7: 769-773
231. Sun XH, Copeland NG, Jenkins NA and Baltimore D (1991) Id proteins Id1 and Id2 selectively inhibit DNA binding by one class of helix-loop-helix proteins. Mol Cell Biol 11: 5603-5611
232. Tahara H, Sato E, Noda A and Ide T (1995) Increase in expression level of p21sdi1/cip1/waf1 with increasing division age in both normal and SV40-transformed human fibroblasts. Oncogene 10: 835-840
233. Tam SW, Shay JW and Pagano M (1994) Differential expression and cell cycle regulation of the cyclin-dependent kinase 4 inhibitor p16Ink4. Cancer Res 54: 5816-5820
234. Tanaka Y, Tang X, Hou DX, Gao H, Kitabayashi I, Gachelin G and Yokoyama K (1992) Phenotypic conversion of SV40-immortalized human diploid fibroblasts to senescing cells by introduction of an antisense gene for SV40-T antigen. Cell Struct Funct 17: 351-362
235. Thompson KV and Holliday R (1983) Genetic effects on the longevity of cultured human fibroblasts. II. DNA repair deficient syndromes. Gerontology 29: 83-88
236. Tresini M, Mawal-Dewan M, Cnstofalo VJ and Sell C (1998) A phosphatidylinositol 3-kinase inhibitor induces a senescent-like growth arrest in human diploid fibroblasts. Cancer Res 58: 1-4
237. Tsuyama N, Miura M, Kitahira M, Ishibashi S and Ide T (1991) SV40 T-antigen is required for maintenance of immortal growth in SV40-transformed human fibroblasts. Cell Struct Funct 16: 55-62
238. Uejima H, Shinohara T, Nakayama Y, Kugoh H and Oshimura M (1998) Mapping a novel cellular-senescence gene to human chromosome 2q37 by irradiation microcell-mediated chromosome transfer. Mol Carcinog 22: 34-45
239. Vallee BL (1995) The function of metallothionein. Neurochem Int 27: 23-33
240. Vaziri H and Benchimol S (1996) From telomere loss to p53 induction and activation of a DNA-damage pathway at senescence: the telomere loss/DNA damage model of cell aging. Exp Gerontol 31: 295-301
241. Vaziri H and Benchimol S (1998) Reconstitution of telomerase activity in normal human cells leads to elongation of telomeres and extended replicative life span. Curr Biol 8: 279-282
242. Vaziri H, Schächter F, Uchida I, Wei L, Zhu X, Effros R, Cohen D and Harley CB (1993) Loss of telomeric DNA during aging of normal and trisomy 21 human lymphocytes. Am J Hum Genet 52: 661-667
243. Vaziri H, West MD, Allsopp RC, Davison TS, Wu YS, Arrowsmith CH, Poirier GG and Benchimol S (1997) ATM-dependent telomere loss in aging human diploid fibroblasts and DNA damage lead to the post-translational activation of p53 protein involving poly(ADP-ribose) polymerase. EMBO J 16: 6018-6033
244. Venable ME, Blobe GC and Obeid LM (1994) Identification of a defect in the phospholipase D/diacylglycerol pathway in cellular senescence. J Biol Chem 269: 26040-26044
245. Venable ME, Lee JY, Smyth MJ, Bielawska A and Obeid LM (1995) Role of ceramide in cellular senescence. J Biol Chem 270: 30701-30708
246. Vertino PM, Issa JP, Pereira-Smith OM and Baylin SB (1994) Stabilization of DNA methyltransferase levels and CpG island hypermethylation precede SV40-induced immortalization of human fibroblasts. Cell Growth Differ 5: 1395-1402
247. Villeponteau B (1997) The heterochromatin loss model of aging. Exp Gerontol 32: 383-394
248. Vogt M, Haggblom C, Yeargin J, Christiansen-Weber T and Haas M (1998) Independent induction of senescence by p16INK4a and p21CIP1 in spontaneously immortalized human fibroblasts. Cell Growth Differ 9: 139-146
249. von Zglinicki T, Saretzki G, Docke W and Lotze C (1995) Mild hyperoxia shortens telomeres and inhibits proliferation of fibroblasts: a model for senescence? Exp Cell Res 220: 186-193
250. Wadhwa R, Kaul SC, Ikawa Y and Sugimoto Y (1991) Protein markers for cellular mortality and immortality. Mutat Res 256: 243-254
251. Wadhwa R, Kaul SC, Ikawa Y and Sugimoto Y (1993a) Identification of a novel member of mouse hsp70 family. Its association with cellular mortal phenotype. J Biol Chem 268: 6615-6621
252. Wadhwa R, Kaul SC, Mitsui Y and Sugimoto Y (1993b) Differential subcellular distribution of mortalin in mortal and immortal mouse and human fibroblasts. Exp Cell Res 207: 442-448
253. Wadhwa R, Kaul SC, Sugimoto Y and Mitsui Y (1993c) Induction of cellular senescence by transfection of cytosolic mortalin cDNA in NIH 3T3 cells. J Biol Chem 268: 22239-22242
254. Wadhwa R, Pereira-Smith OM, Reddel RR, Sugimoto Y, Mitsui Y and Kaul SC (1995) Correlation between complementation group for immortality and the cellular distribution of mortalin. Exp Cell Res 216: 101-106
255. Wadhwa R, Takano S, Robert M, Yoshida A, Nomura H, Reddel RR, Mitsui Y and Kaul SC (1998) Inactivation of tumor suppressor p53 by mot-2, a hsp70 family member. J Biol Chem 273: 29586-29591
256. Wang J, Xie LY, Allan S, Beach D and Hannon GJ (1998) Myc activates telomerase. Genes Dev 12: 1769-1774
257. Wang S, Nath N, Adlam M and Chellappan S (1999) Prohibitin, a potential tumor suppressor, interacts with RB and regulates E2F function. Oncogene 18: 3501-3510
258. Wei S and Sedivy JM (1999) Expression of catalytically active telomerase does not prevent premature senescence caused by overexpression of oncogenic Ha-Ras in normal human fibroblasts. Cancer Res 59: 1539-1543
259. Weinberg RA (1997) The cat and mouse games that genes, viruses, and cells play. Cell 88: 573-575
260. Weirich-Schwaiger H, Weirich HG, Gruber B, Schweiger M and Hirsch-Kauffmann M (1994) Correlation between senescence and DNA repair in cells from young and old individuals and in premature aging syndromes. Mutat Res 316: 37-48
261. Weng NP, Levine BL, June CH and Hodes RJ (1996) Regulated expression of telomerase activity in human T lymphocyte development and activation. J Exp Med 183: 2471-2479
262. Whitaker NJ, Bryan TM, Bonnefin P, Chang AC, Musgrove EA, Braithwaite AW and Reddel RR (1995) Involvement of RB-1, p53, p16INK4 and telomerase in immortalisation of human cells. Oncogene 11: 971-976
263. Wilson VL and Jones PA (1983) DNA methylation decreases in aging but not in immortal cells. Science 220: 1055-1057
264. Wright WE, Pereira-Smith OM and Shay JW (1989) Reversible cellular senescence: implications for immortalization of normal human diploid fibroblasts. Mol Cell Biol 9: 3088-3092
265. Wright WE, Brasiskyte D, Piatyszek MA and Shay JW (1996) Experimental elongation of telomeres extends the lifespan of immortal x normal cell hybrids. EMBO J 15: 1734-1741
266. Wynford-Thomas D (1996) p53: guardian of cellular senescence. J Pathol 180: 118-121
267. Xu HJ, Zhou Y, Ji W, Perng GS, Kruzelock R, Kong CT, Bast RC, Mills GB, Li J and Hu SX (1997) Reexpression of the retinoblastoma protein in tumor cells induces senescence and telomerase inhibition. Oncogene 15: 2589-2596
268. Yasumoto S, Kunimura C, Kikuchi K, Tahara H, Ohji H, Yamamoto H, Ide T and Utakoji T (1996) Telomerase activity in normal human epithelial cells. Oncogene 13: 433-439
269. Yegorov YE, Akimov SS, Hass R, Zelenin AV and Prudovsky IA (1998) Endogenous beta-galactosidase activity in continuously nonproliferating cells. Exp Cell Res 243: 207-211
270. Yu CE, Oshima J, Fu YH, Wijsman EM, Hisama F, Alisch R, Matthews S, Nakura J, Miki T, Ouais S, Martin GM, Mulligan J and Schellenberg GD (1996) Positional cloning of the Werner's syndrome gene [see comments]. Science 272: 258-262
271. Yu GL, Bradley JD, Attardi LD and Blackburn EH (1990) In vivo alteration of telomere sequences and senescence caused by mutated Tetrahymena telomerase RNAs. Nature 344: 126-132
272. Zhu J, Woods D, McMahon M and Bishop JM (1998) Senescence of human fibroblasts induced by oncogenic Raf. Genes Dev 12: 2997-3007
273. Zhu J, Wang H, Bishop JM and Blackburn EH (1999) Telomerase extends the lifespan of virus-transformed human cells without net telomere lengthening. Proc Natl Acad Sci USA 96: 3723-3728